Drug Database
Back to search

United States· US:23155-170_f4991976-8a87-4a00-839f-3f62c561c230

Zoledronic acid

A zoledronic acid product containing zoledronic acid, registered in United States by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.. The same ATC class is registered in 14 of our 19 countries.

ATC M05BA08US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedZoledronic acidATCM05BA08REGISTER NO.US:23155-170_f4991976…PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about zoledronic acidAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Zoledronic acid is registered in 14 of 19 countries.

Countries holding a registration under ATC M05BA08 (zoledronic acid), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 8 of them publish a price we can compare per daily dose
Search zoledronic acid products by name

Zoledronic acid · ATC M05BA08

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of zoledronic acid costs, country by country.

Normalised to the WHO defined daily dose (4 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Zoledronic acid · price per daily dose (4 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$212.85
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
ZOLEDRONIC ACID
Manufacturer
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
Country
United States (US)
ATC code
M05BA08
ATC class
Zoledronic acid
Defined daily dose
4 mg, P
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    2315517031
    1 VIAL, GLASS in 1 CARTON (23155-170-31) / 5 mL in 1 VIAL, GLASS
  • ndc11
    23155-170-31

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

251 interactions on record for zoledronic acid.

Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check zoledronic acid against other medicinesHow interaction checks work

Zoledronic acid · interactions on record

251 records

  • 12 severe
  • 57 moderate
  • 180 info

Most severe, free to view

  • EtelcalcetideH05BX04severe
  • SirolimusL01EG04severe
  • SirolimusL04AA10severe
  • TacrolimusL04AD02severe

2 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Zoledronic acid in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All zoledronic acid products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Zoledronic Acid Koanaa, Zoledronsäure Fresenius Kabi
  • Belgium · Acide Zolédronique Fresenius Kabi, Zoledronate Eg
  • Bulgaria · Золедронова Киселина Ейсфарма, Золедронова Киселина Ромфарм
  • Cyprus · Nordeloz, Zoledronic Acid Altan
  • Czechia · Zoledronic Acid Fresenius Kabi, Zomikos
  • Germany · Aszora, Clastizol
  • Denmark · Zoledo, Zoledronsyre Fresenius Kabi
  • Estonia · Zoledronic Acid Fresenius Kabi
  • Spain · Ácido Zoledrónico Accord, Ácido Zoledrónico Altan
  • Finland · Zobiore, Zoledronic Acid Fresenius Kabi
  • France · Acide Zoledronique Altan, Acide Zoledronique Biogaran
  • United Kingdom (Northern Ireland) · Zerlinda, Zoledronic Acid
  • Greece · Bonevin, Nordeloz
  • Croatia · Zolenat
  • Hungary · Osporil, Zoledronsav Fresenius Kabi
  • Ireland · Zerlinda, Zoledronic Acid
  • Iceland · Aclasta, Aszora
  • Italy · Acido Zoledronico Altan, Acido Zoledronico Fresenius Kabi
  • Liechtenstein · Aclasta, Zoledronic Acid Accord
  • Lithuania · Zoledronic Acid Fresenius Kabi
  • Luxembourg · Acide Zolédronique Fresenius Kabi, Zoledronate Eg
  • Latvia · Zoledronic Acid Fresenius Kabi
  • Netherlands · Zoledroninezuur Accord, Zoledroninezuur Cf
  • Norway · Aclasta, Zoledo
  • Poland · Osporil, Zerlinda
  • Portugal · Ácido Zoledrónico Accord, Ácido Zoledrónico Altan
  • Romania · Acid Zoledronic Accord, Acid Zoledronic Fresenius Kabi
  • Sweden · Zerlinda, Zoledronic Acid Accord
  • Slovenia · Zoledronska Kislina Accord, Zoledronska Kislina Fresenius Kabi
  • Slovakia · Kyselina, Kyselina Zoledrónová Sandoz

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/59f371de-c33a-4bc1-b549-2dc3aa1a9be0
GET /v1/drugs/59f371de-c33a-4bc1-b549-2dc3aa1a9be0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAVENOUS",
  "source": "ndc",
  "strength": "4",
  "substance": "ZOLEDRONIC ACID",
  "productndc": "23155-170",
  "dosage_form": "INJECTION, SOLUTION, CONCENTRATE",
  "dea_schedule": null,
  "strength_unit": "mg/5mL",
  "application_number": "ANDA201783",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about zoledronic acid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console